Elitek Lyophilisate For Solution For Injection 1.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Elitek: Lyophilisate for solution for injection (1.5mg)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

RASBURICASE (ras BURE i kase) breaks down uric acid in the blood. It is used to prevent and to treat high levels of uric acid caused by cancer treatment.

In-Depth Information

Elitek 1.5mg Powder for Injection

NDC: 000245150
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hyperuricemia

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Protect from freezing
Elitek 1.5mg Powder for Injection
Close All Sections Show

Reported Side Effects for Elitek 1.5mg Powder for Injection

Close Show
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hemolysis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
High Methemoglobin Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Hypoxia Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
<4.3%*
Severity: MILD
Onset: RAPID
Headache Incidence:
<26.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<13.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
<3.3%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
<4.3%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<3.3%*
Severity: SEVERE
Onset: DELAYED
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Upset Stomach Incidence:
1.1%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
1.1%*
Severity: SEVERE
Onset: EARLY
Fluid Retention Incidence:
2.2-3.3%*
Severity: SEVERE
Onset: DELAYED
High Bilirubin Level Incidence:
2.2-3.3%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
3.3-4.3%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
3.3-4.3%*
Severity: SEVERE
Onset: EARLY
Low Phosphate Level Incidence:
4.3-6.5%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
5.4-6.5%*
Severity: SEVERE
Onset: DELAYED
Antibody Formation Incidence:
6.0-18.0%*
Severity: MODERATE
Onset: DELAYED
High Phosphate Levels Incidence:
9.8-15.2%*
Severity: MODERATE
Onset: DELAYED
Mouth Sores Incidence:
15.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
20.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
20.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
46.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Elitek

Close Show

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5